General lifestyle
Talquetamab GI Myths Exposed by General Lifestyle
In 2023, talquetamab received FDA approval for treating relapsed multiple myeloma, and many patients notice gastrointestinal changes. I’m Emma Nakamura, and I’ll explain how common myths about its gut side effects can be debunked with simple lifestyle habits. Understanding the real cause helps you take control. Medical Disclaimer: